vs

Side-by-side financial comparison of ASP Isotopes Inc. (ASPI) and TRIO-TECH INTERNATIONAL (TRT). Click either name above to swap in a different company.

ASP Isotopes Inc. is the larger business by last-quarter revenue ($16.7M vs $15.6M, roughly 1.1× TRIO-TECH INTERNATIONAL). On growth, ASP Isotopes Inc. posted the faster year-over-year revenue change (1295.7% vs 81.6%). TRIO-TECH INTERNATIONAL produced more free cash flow last quarter ($-152.0K vs $-47.4M).

ASP Isotopes Inc. is a specialty materials firm focused on developing and producing high-purity custom isotopes. Its products serve key sectors including nuclear medicine, targeted cancer therapies, advanced energy, and industrial research, with customers across North America, Europe and Asia Pacific.

Trio-Tech International is a global provider of semiconductor testing and burn-in solutions, alongside specialized manufacturing services for electronic components. It serves clients across the semiconductor, aerospace, and consumer electronics sectors, with operational footprints spanning North America, Asia, and Europe, delivering custom reliability testing systems and related support services.

ASPI vs TRT — Head-to-Head

Bigger by revenue
ASPI
ASPI
1.1× larger
ASPI
$16.7M
$15.6M
TRT
Growing faster (revenue YoY)
ASPI
ASPI
+1214.1% gap
ASPI
1295.7%
81.6%
TRT
More free cash flow
TRT
TRT
$47.3M more FCF
TRT
$-152.0K
$-47.4M
ASPI

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ASPI
ASPI
TRT
TRT
Revenue
$16.7M
$15.6M
Net Profit
$126.0K
Gross Margin
12.5%
16.0%
Operating Margin
0.6%
Net Margin
0.8%
Revenue YoY
1295.7%
81.6%
Net Profit YoY
-586.8%
-75.1%
EPS (diluted)
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASPI
ASPI
TRT
TRT
Q4 25
$16.7M
$15.6M
Q3 25
$4.9M
$15.5M
Q2 25
$10.7M
Q1 25
$7.4M
Q4 24
$8.6M
Q3 24
$9.8M
Q2 24
$9.7M
Q1 24
$10.4M
Net Profit
ASPI
ASPI
TRT
TRT
Q4 25
$126.0K
Q3 25
$-12.9M
$77.0K
Q2 25
$183.0K
Q1 25
$-495.0K
Q4 24
$507.0K
Q3 24
$-236.0K
Q2 24
$243.0K
Q1 24
$70.0K
Gross Margin
ASPI
ASPI
TRT
TRT
Q4 25
12.5%
16.0%
Q3 25
8.7%
16.7%
Q2 25
24.6%
Q1 25
26.8%
Q4 24
25.7%
Q3 24
23.7%
Q2 24
27.5%
Q1 24
26.0%
Operating Margin
ASPI
ASPI
TRT
TRT
Q4 25
0.6%
Q3 25
-306.1%
0.3%
Q2 25
4.4%
Q1 25
-4.6%
Q4 24
-0.0%
Q3 24
1.4%
Q2 24
3.7%
Q1 24
0.6%
Net Margin
ASPI
ASPI
TRT
TRT
Q4 25
0.8%
Q3 25
-263.7%
0.5%
Q2 25
1.7%
Q1 25
-6.7%
Q4 24
5.9%
Q3 24
-2.4%
Q2 24
2.5%
Q1 24
0.7%
EPS (diluted)
ASPI
ASPI
TRT
TRT
Q4 25
$0.01
Q3 25
$-0.15
$0.02
Q2 25
$0.11
Q1 25
$-0.12
Q4 24
$0.06
Q3 24
$-0.06
Q2 24
$0.05
Q1 24
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASPI
ASPI
TRT
TRT
Cash + ST InvestmentsLiquidity on hand
$333.3M
$16.5M
Total DebtLower is stronger
$14.4M
$581.0K
Stockholders' EquityBook value
$204.2M
$33.5M
Total Assets
$498.0M
$45.7M
Debt / EquityLower = less leverage
0.07×
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASPI
ASPI
TRT
TRT
Q4 25
$333.3M
$16.5M
Q3 25
$113.9M
$17.4M
Q2 25
$16.7M
Q1 25
$17.6M
Q4 24
$16.5M
Q3 24
$15.5M
Q2 24
$16.5M
Q1 24
$17.0M
Total Debt
ASPI
ASPI
TRT
TRT
Q4 25
$14.4M
$581.0K
Q3 25
$13.9M
$622.0K
Q2 25
$684.0K
Q1 25
$729.0K
Q4 24
$782.0K
Q3 24
$923.0K
Q2 24
$874.0K
Q1 24
$984.0K
Stockholders' Equity
ASPI
ASPI
TRT
TRT
Q4 25
$204.2M
$33.5M
Q3 25
$74.1M
$34.1M
Q2 25
$34.0M
Q1 25
$32.3M
Q4 24
$31.8M
Q3 24
$33.1M
Q2 24
$31.3M
Q1 24
$31.2M
Total Assets
ASPI
ASPI
TRT
TRT
Q4 25
$498.0M
$45.7M
Q3 25
$225.9M
$47.4M
Q2 25
$41.1M
Q1 25
$40.0M
Q4 24
$39.8M
Q3 24
$42.9M
Q2 24
$42.5M
Q1 24
$43.1M
Debt / Equity
ASPI
ASPI
TRT
TRT
Q4 25
0.07×
0.02×
Q3 25
0.19×
0.02×
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.03×
Q2 24
0.03×
Q1 24
0.03×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASPI
ASPI
TRT
TRT
Operating Cash FlowLast quarter
$-37.8M
$134.0K
Free Cash FlowOCF − Capex
$-47.4M
$-152.0K
FCF MarginFCF / Revenue
-284.7%
-1.0%
Capex IntensityCapex / Revenue
57.9%
1.8%
Cash ConversionOCF / Net Profit
1.06×
TTM Free Cash FlowTrailing 4 quarters
$137.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASPI
ASPI
TRT
TRT
Q4 25
$-37.8M
$134.0K
Q3 25
$-8.9M
$933.0K
Q2 25
$-664.0K
Q1 25
$781.0K
Q4 24
$2.1M
Q3 24
$-1.9M
Q2 24
$199.0K
Q1 24
$1.2M
Free Cash Flow
ASPI
ASPI
TRT
TRT
Q4 25
$-47.4M
$-152.0K
Q3 25
$-12.0M
$887.0K
Q2 25
$-1.2M
Q1 25
$623.0K
Q4 24
$1.9M
Q3 24
$-1.9M
Q2 24
$-135.0K
Q1 24
$1.1M
FCF Margin
ASPI
ASPI
TRT
TRT
Q4 25
-284.7%
-1.0%
Q3 25
-245.5%
5.7%
Q2 25
-11.4%
Q1 25
8.4%
Q4 24
22.4%
Q3 24
-19.7%
Q2 24
-1.4%
Q1 24
10.6%
Capex Intensity
ASPI
ASPI
TRT
TRT
Q4 25
57.9%
1.8%
Q3 25
64.4%
0.3%
Q2 25
5.2%
Q1 25
2.1%
Q4 24
2.1%
Q3 24
0.7%
Q2 24
3.4%
Q1 24
0.5%
Cash Conversion
ASPI
ASPI
TRT
TRT
Q4 25
1.06×
Q3 25
12.12×
Q2 25
-3.63×
Q1 25
Q4 24
4.16×
Q3 24
Q2 24
0.82×
Q1 24
16.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASPI
ASPI

Segment breakdown not available.

TRT
TRT

Semiconductor Backend Solutions$12.4M79%
Industrial Electronics$3.3M21%

Related Comparisons